Exact Mass: 309.0471

Exact Mass Matches: 309.0471

Found 24 metabolites which its exact mass value is equals to given mass value 309.0471, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Hydroxylumiracoxib

2-{2-[(2-chloro-6-fluoro-4-hydroxyphenyl)amino]-5-methylphenyl}acetic acid

C15H13ClFNO3 (309.0568)


Hydroxylumiracoxib is a metabolite of lumiracoxib. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as Prestige by the media). Lumiracoxib has several distinctive features. (Wikipedia)

   

methyl 1-(4-chlorophenyl)-5-(2-methoxy-2-oxoethyl)-1H-1,2,3-triazole-4-carboxylate

methyl 1-(4-chlorophenyl)-5-(2-methoxy-2-oxoethyl)-1H-1,2,3-triazole-4-carboxylate

C13H12ClN3O4 (309.0516)


   
   
   
   

2-(2-Benzenesulfonamido-5-pyrimidinyloxy)acetic acid

2-(2-Benzenesulfonamido-5-pyrimidinyloxy)acetic acid

C12H11N3O5S (309.0419)


   

2-(4-FLUOROPHENYLSULFONAMIDO)-2-PHENYLACETIC ACID

2-(4-FLUOROPHENYLSULFONAMIDO)-2-PHENYLACETIC ACID

C14H12FNO4S (309.0471)


   

7-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

7-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

C15H13ClFNO3 (309.0568)


   

4-(2,4-difluorophenoxy)-n-hydroxy-3-nitrobenzenecarboximidamide

4-(2,4-difluorophenoxy)-n-hydroxy-3-nitrobenzenecarboximidamide

C13H9F2N3O4 (309.0561)


   

3-(Boc-amino)-6,6-dichlorobicyclo[3.1.0]hexane-3-carboxylic Acid

3-(Boc-amino)-6,6-dichlorobicyclo[3.1.0]hexane-3-carboxylic Acid

C12H17Cl2NO4 (309.0535)


   

4-Bromo-1-(tert-butyldimethylsilyl)indole

4-Bromo-1-(tert-butyldimethylsilyl)indole

C14H20BrNSi (309.0548)


   

6-Bromo-1-(tert-butyldimethylsilyl)indole

6-Bromo-1-(tert-butyldimethylsilyl)indole

C14H20BrNSi (309.0548)


   

4-(4-Aminoanilino)-3-nitrobenzenesulphonic acid

4-(4-Aminoanilino)-3-nitrobenzenesulphonic acid

C12H11N3O5S (309.0419)


   

5-bromo-1-(tert-butyldimethylsilyl)-1h-indole

5-bromo-1-(tert-butyldimethylsilyl)-1h-indole

C14H20BrNSi (309.0548)


   

2-(4-Aminoanilino)-5-nitrobenzenesulphonic acid

2-(4-Aminoanilino)-5-nitrobenzenesulphonic acid

C12H11N3O5S (309.0419)


   

Lumiracoxib metabolite M23

Lumiracoxib metabolite M23

C15H13ClFNO3 (309.0568)


   

N-(2-Ferrocenylethyl)maleimide

N-(2-Ferrocenylethyl)maleimide

C16H15FeNO2-6 (309.0452)


   

N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide

N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide

C14H15NO3S2 (309.0493)


   

4,5-Dimethyl-2-[[oxo(thiophen-2-yl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester

4,5-Dimethyl-2-[[oxo(thiophen-2-yl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester

C14H15NO3S2 (309.0493)


   

(2Z)-2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)methylidene]-4-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-3-olate

(2Z)-2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)methylidene]-4-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-3-olate

C17H9O6- (309.0399)


   

({5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(propyl)amine

({5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(propyl)amine

C13H16BrN3O (309.0477)


   

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(propyl)amine

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(propyl)amine

C13H16BrN3O (309.0477)


   

{[(5z)-5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}(propyl)amine

{[(5z)-5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}(propyl)amine

C13H16BrN3O (309.0477)